CBLL

CeriBell, Inc. NASDAQ Listed Oct 11, 2024

Healthcare ·Medical - Devices ·US · ceribell.com

$20.37

After hrs $20.20 +0.00%

Mkt Cap $771.5M

52w Low $10.85 70.6% of range 52w High $24.33

50d MA $19.20 200d MA $16.73

P/E (TTM) -14.0x

EV/EBITDA -15.2x

P/B 4.8x

Debt/Equity 0.1x

ROE -34.4%

P/FCF -19.3x

RSI (14) —

ATR (14) —

Beta 0.93

50d MA $19.20

200d MA $16.73

Avg Volume 292.0K

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

CIK (SEC)

1861107

Phone

800 436 0826

360 North Pastoria Avenue · Sunnyvale, CA 94085 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 24, 2026	AMC	-0.43	-0.36	+16.3%	19.90	-5.4%	-4.8%	-2.6%	-6.2%	-8.7%	-11.9%	—
Nov 4, 2025	AMC	-0.43	-0.37	+14.0%	10.92	+3.0%	+7.9%	+5.9%	+9.7%	+7.9%	+14.7%	—
Aug 5, 2025	AMC	-0.40	-0.38	+5.0%	15.08	-0.5%	-15.3%	-16.6%	-14.4%	-19.6%	-22.4%	—
May 8, 2025	AMC	-0.43	-0.36	+16.3%	17.10	+4.0%	-6.6%	+0.4%	-2.9%	-3.7%	+2.9%	—
Feb 25, 2025	AMC	-0.32	-0.40	-25.0%	25.54	-0.5%	-1.3%	-7.0%	-9.0%	-3.6%	-7.0%	—
Nov 12, 2024	AMC	-0.82	-1.85	-125.6%	28.85	+0.5%	-3.4%	-4.5%	-8.0%	-13.3%	-11.4%	—
Oct 11, 2024	AMC	—	-1.59	—	25.00	+1.2%	+2.0%	+2.1%	+5.7%	+6.0%	+6.7%	—
Mar 31, 2024	AMC	—	-1.59	—	—	—	—	—	—	—	—	—
Dec 31, 2023	AMC	—	-0.35	—	—	—	—	—	—	—	—	—
Sep 30, 2023	AMC	—	-0.30	—	—	—	—	—	—	—	—	—
Jun 30, 2023	AMC	—	-1.35	—	—	—	—	—	—	—	—	—
Mar 31, 2023	AMC	—	-1.35	—	—	—	—	—	—	—	—	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Jan 28	BTIG	Maintains	Buy → Buy	—	$21.89	$21.88	-0.0%	-6.1%	-6.7%	-5.8%	-7.6%	-6.4%
Dec 17	Canaccord Genuity	Maintains	Buy → Buy	—	$21.99	$22.16	+0.8%	-1.8%	-2.9%	-3.6%	-4.1%	-3.2%
Dec 15	BTIG	Maintains	Buy → Buy	—	$20.93	$21.20	+1.3%	+4.6%	+5.1%	+3.2%	+2.0%	+1.3%
Nov 5	JP Morgan	Maintains	Overweight → Overweight	—	$10.92	$11.25	+3.0%	+7.9%	+5.9%	+9.7%	+7.9%	+14.7%
Nov 5	TD Cowen	Maintains	Buy → Buy	—	$10.92	$11.25	+3.0%	+7.9%	+5.9%	+9.7%	+7.9%	+14.7%
Feb 26	Canaccord Genuity	Maintains	Buy → Buy	—	$25.54	$25.40	-0.5%	-1.3%	-7.0%	-9.0%	-3.6%	-7.0%
Dec 9	Canaccord Genuity	Maintains	Buy → Buy	—	$30.24	$30.89	+2.1%	-0.7%	-2.0%	-2.1%	-3.4%	-3.4%
Dec 9	TD Cowen	Maintains	Buy → Buy	—	$30.24	$30.89	+2.1%	-0.7%	-2.0%	-2.1%	-3.4%	-3.4%
Nov 13	Canaccord Genuity	Maintains	Buy → Buy	—	$28.85	$29.00	+0.5%	-3.4%	-4.5%	-8.0%	-13.3%	-11.4%

Date	Insider	Title	Type	Shares	Price	Value	Owned After	D1%	D5%
May 5, 2026	Chao Xingjuan	President and CEO	Sell	23,554	$20.09	$473K	836,347	-0.88%	—
May 5, 2026	Chao Xingjuan	President and CEO	Sell	1,446	$20.12	$29K	836,347	-0.88%	—
May 5, 2026	Chao Xingjuan	President and CEO	Sell	14,000	$20.12	$282K	836,347	-0.88%	—
May 1, 2026	Woo Raymond	Chief Technology Officer	Sell	6,611	$20.45	$135K	197,648	+0.49%	—
May 1, 2026	Woo Raymond	Chief Technology Officer	Sell	3,024	$20.43	$62K	197,648	+0.49%	—
May 1, 2026	Woo Raymond	Chief Technology Officer	Sell	1,469	$20.39	$30K	197,648	+0.49%	—

Data updated apr 25, 2026 12:05am · Source: massive.com